arrow
D

Dylan Isaacson

cleveland clinic
H指数:14
被引数:937

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

True hepatic artery aneurysm repair: anatomical complexity and operative adaptability comparing open versus endovascular approach

真性肝动脉瘤修复:开放手术与血管内介入治疗在解剖复杂性和手术适应性方面的比较

HPB
IF2.4
2026-06-010
PRE
ROBOTIC KIDNEY-PANCREAS TRANSPLANTATION - THE CLEVELAND CLINIC EXPERIENCE WITH IPSILATERAL ALLOGRAFT PLACEMENT AND SINGLE PORT APPROACH

机器人肾-胰联合移植——克利夫兰医学中心关于同侧移植物放置和单孔入路的经验

2026-05-010
PRE
Evidence rising, integration lagging: the bottleneck of circulating free and tumor DNA application in liver transplantation for hepatocellular carcinoma

证据增多,整合滞后:循环游离和肿瘤DNA在肝移植治疗肝癌中的应用瓶颈

2026-05-011
PRE
First Experience with Hypothermic Oxygenated Perfusion in Human Uteri: Feasibility and Metabolic Characterization

首次在人类子宫中使用低温氧合灌注的初步经验:可行性与代谢特征

2026-04-080
OAAI
Urologic malignancy risk with chronic tumor necrosis factor-alpha inhibitor (TNF-I) exposure: a multicenter, retrospective cohort study

泌尿系统恶性肿瘤风险与慢性肿瘤坏死因子-α抑制剂(TNF-I)暴露的关系:一项多中心、回顾性队列研究

2026-02-260
OAAI
PRECISE-Tx: Implementation of a Prospective Transplant Oncology Framework for Serial ctDNA Surveillance and Disease-Specific Mutation Profiling for HCC, CRLM and CCA

PRECISE-Tx:用于HCC、CRLM和CCA的系列ctDNA监测和疾病特异性突变谱绘的前瞻性移植肿瘤学框架的实施

2026-01-150
OAAI
The Safe Haven of Recipient Splenectomy in Living Donor Liver Transplantation: An Analysis of Survival, Complications and Long-term Outcomes

供者脾切除术在活体肝移植中的安全性与分析:生存率、并发症及长期结局分析

2026-01-150
PRE